Laddar...

Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab

The early remission of diabetic macular edema (DME) often occurs in eyes treated with anti-vascular endothelial growth factor (VEGF) treatment. We retrospectively reviewed and characterized eyes with early remission of DME at six months in 80 eyes under pro re nata (PRN) intravitreal ranibizumab (IV...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Sci Rep
Huvudupphovsmän: Yoshitake, Tatsuya, Murakami, Tomoaki, Suzuma, Kiyoshi, Fujimoto, Masahiro, Dodo, Yoko, Tsujikawa, Akitaka
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2019
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527559/
https://ncbi.nlm.nih.gov/pubmed/31110273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-44078-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!